Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Open-label, Ambulatory Blood Pressure Monitoring (ABPM) Dose Titration Study to Evaluate the Safety and Efficacy of an Olmesartan Medoxomil and Amlodipine Based Treatment Regimen in Hypertensive, Type 2 Diabetic Subjects

NCT00654745 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT00654745
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00654745 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Open-label, Ambulatory Blood Pressure Monitoring (ABPM) Dose Titration Study to Evaluate the Safety and Efficacy of an Olmesartan Medoxomil and Amlodipine Based Treatment Regimen in Hypertensive, Type 2 Diabetic Subjects
Lead sponsor
Daiichi Sankyo
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2008
Completion date
June 30, 2009
Enrollment
207 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, type 2 diabetes